AGT and cardiac hypertrophy: This notion is supported by recent research showing that Ang II markedly increased ROS production in mitochondria and that treatment with the mitochondrial-targeted antioxidant Mito-TEMPO significantly alleviated Ang II-induced cardiac hypertrophy [34].